- 专利标题： BICYCLIC AMINES AS CDK2 INHIBITORS
-
申请号： US18064080申请日： 2022-12-09
-
公开(公告)号： US20230183250A1公开(公告)日： 2023-06-15
- 发明人: Joshua Hummel , David M. Burns , Ding-Quan Qian , Xiaozhao Wang
- 申请人： Incyte Corporation
- 申请人地址： US DE Wilmington
- 专利权人： Incyte Corporation
- 当前专利权人： Incyte Corporation
- 当前专利权人地址： US DE Wilmington
- 主分类号： C07D487/04
- IPC分类号： C07D487/04
摘要：
The present application provides bicyclic amines of Formula (I):
and their pharmaceutically acceptable salts thereof, that are inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.
and their pharmaceutically acceptable salts thereof, that are inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.
公开/授权文献
- US11976073B2 Bicyclic amines as CDK2 inhibitors 公开/授权日：2024-05-07
信息查询
